Hiroomi Tada
Directeur Technique/Scientifique/R&D chez TYRA BIOSCIENCES, INC.
Fortune : 1 M $ au 31/05/2024
Profil
Mr. Hiroomi Tada is a Chief Medical Officer at Tyra Biosciences, Inc. Mr. Tada was previously employed as an Executive Director by IQVIA, Inc., a Chief Medical Officer by Notable Labs, Inc., a Vice President-Translational Sciences by Target Therapeutics, Inc., an Assistant Professor by Temple University School of Medicine, and an Assistant Professor by UMass Chan Medical School.
He received his undergraduate degree from Haverford College, a doctorate degree from Sidney Kimmel Medical College and a doctorate degree from Thomas Jefferson University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
0,16% | 26/03/2024 | 86 435 ( 0,16% ) | 1 M $ | 31/05/2024 |
Postes actifs de Hiroomi Tada
| Sociétés | Poste | Début |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/11/2020 |
Anciens postes connus de Hiroomi Tada
| Sociétés | Poste | Fin |
|---|---|---|
Notable Labs, Inc.
 Notable Labs, Inc. Hospital/Nursing ManagementHealth Services Notable Labs, Inc. provides personalized testing services for cancer patients. Its testing prioritizes combinations of FDA-approved treatments that can be prescribed by a doctor without a clinical trial. The company was founded by Peter Quinzio and Matthew De Silva in 2013 and is headquartered in Foster City, CA. | Directeur Technique/Scientifique/R&D | - |
| Temple University School of Medicine | Corporate Officer/Principal | - |
| IMS HEALTH, INC. | Directeur/Membre du Conseil | - |
| UMass Chan Medical School | Corporate Officer/Principal | - |
Target Therapeutics, Inc.
 Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Formation de Hiroomi Tada
| Thomas Jefferson University | Doctorate Degree |
| Haverford College | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TYRA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
Notable Labs, Inc.
Notable Labs, Inc. Hospital/Nursing ManagementHealth Services Notable Labs, Inc. provides personalized testing services for cancer patients. Its testing prioritizes combinations of FDA-approved treatments that can be prescribed by a doctor without a clinical trial. The company was founded by Peter Quinzio and Matthew De Silva in 2013 and is headquartered in Foster City, CA. | Health Services |
